Physician profile
Robert Gutman
NPI 1043268501
$28,406.05
in general payments reported to CMS, 2019-2025
17 companies · $704 in 2025
The $704 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,627 · 2020: $1,652 · 2021: $1,542 · 2022: $1,667 · 2023: $9,557 · 2024: $6,659 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $3,405 · Travel and Lodging: $1,818 · Entertainment: $18.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,677.50 |
| Food and Beverage | $3,405.36 |
| Travel and Lodging | $1,817.74 |
| Entertainment | $18.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,557.49 | 2019-2025 | Advantage System, Solyx Sis System, Upsylon |
| Coloplast Corp | $7,808.60 | 2019-2025 | Altis |
| Axonics, INC. | $1,126.67 | 2022-2024 | Axonics |
| Sumitomo Pharma America, INC. | $222.38 | 2023-2025 | Gemtesa |
| Abbvie INC. | $174.86 | 2023-2025 | |
| Caldera Medical, INC | $134.22 | 2021 | |
| Urovant Sciences INC | $126.93 | 2021-2022 | |
| Allergan, INC. | $46.16 | 2021-2022 | |
| Convatec INC. | $34.17 | 2022 | |
| Contura, INC. | $29.78 | 2020 | |
| Medtronic, INC. | $25.74 | 2025 | Interstim |
| Avita Medical Americas, LLC | $22.33 | 2025 | Recell, Cohealyx, Permeaderm |
| Bluewind Medical | $22.22 | 2025 | Revi |
| Valencia Technologies Corporation | $20.93 | 2023 | Ecoin Device Kit |
| Provepharm INC. | $18.40 | 2024 | Bludigo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $18.40 | 2019 | |
| Astellas Pharma US INC | $16.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gutman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.